An exporter wanting to turn a term receivable into immediate cash has two routes, presented as competing and doing different things: selling the receivable, or insuring it and financing it. Forfaiting and non-recourse discounting belong to the first; credit insurance backed by financing belongs to the second. An earlier module dealt with the circulation of the receivable from the claim's point of view, asking who notifies, who is indemnified and who is subrogated. Here we take it from the point of view of the earlier decision: what does one choose, and what does one really get for what one pays.
The fundamental difference concerns what leaves the balance sheet. A receivable sold without recourse leaves the assets: the exporter receives a price, the receivable belongs to the forfaiter, and if the debtor does not pay, that is no longer the seller's concern. An insured receivable stays on the assets: it is covered, but the cover is conditional, it carries a coverage share, it assumes declarations and diligence, and the credit risk remains with the exporter until the insurer pays. In accounting terms, only the first transaction produces derecognition, and for a company managing its net debt, that is often the main reason for the choice.
The second difference concerns what the price buys, and it explains a cost gap finance departments first find outrageous. The forfaiter buys a receivable it cannot turn back on the seller: it takes the debtor's risk, the country's, and interest rate risk to maturity, unconditionally and with no deductible. The insurer, for its part, sells a conditional cover: it pays only after a period, on a fraction, and only if the insured has met its obligations. The first is necessarily dearer for the same risk, not because it is greedy but because it sells a certainty where the other sells a cover.
One must also know that the expression without recourse does not mean without exception, and that is where files go wrong. Even without credit recourse, the transferor ordinarily warrants the existence and validity of the receivable: its regular creation, performance of the commercial contract, the absence of dispute, the quality of the documentation. If the buyer does not pay because it disputes the goods, the forfaiter turns back on the seller not under the credit but under that warranty of validity, and the exporter that believed it had transferred everything discovers it transferred the debtor's risk and kept its own.
The two techniques in fact combine more often than they compete, and the combination is where mistakes are made. A financier frequently requires insurance cover as a condition of its discount, and takes an assignment of the policy's benefit. One then has a sold receivable whose acquirer is protected by insurance taken out by the seller, which stacks two logics: the insurer raises against the assignee the defences arising with the transferor, and the financier discovers it is buying protection whose soundness depends on someone else's conduct. It is workable, provided it has been written down who notifies, who recovers and who answers for the policy's obligations.
The choice finally turns on the structure of the transaction rather than on the headline price. Forfaiting handles well a single large receivable, evidenced by bills of exchange or banking documentation, on an identifiable debtor and for a defined tenor. Credit insurance handles well a regular flow of multiple receivables, where pooling operates and unit cost falls. Trying to forfait a flow of small receivables is expensive in fixed costs; trying to insure a single exceptional receivable amounts to buying insurance's dearest structure. Each is misused when put in the other's place.
The method comes down to three questions and none of them is about the rate first. Do I need the receivable to leave the balance sheet, or only to be protected against its default? Am I able to warrant the existence and validity of the receivable without reservation, that is, is my commercial performance beyond challenge? And is this a one-off transaction or a regular flow? The answers designate the technique, and price then comes in to compare two things of the same nature instead of setting a certainty against a cover.
A French manufacturer is owed 4.2 million euros by a Southeast Asian buyer, payable in six half-yearly bills avalized by the buyer's bank. The finance director compares two offers: non-recourse forfaiting at a discount rate he considers high, and an appreciably cheaper single-buyer policy, backed by ordinary bank financing. He picks the second, explaining that the risk covered is the same for less. Three details then emerge: final acceptance of the equipment has not been pronounced, the buyer has raised two technical reservations, and the group is committed to its lenders on a net debt ratio measured at December 31. What should be said?
The price comparison was between two things of different natures, and the three details show that the cheaper was not the less costly. On the balance sheet first: only forfaiting produces derecognition, the insured receivable stays on the assets with the financing as debt against it, so that the net debt ratio measured at December 31 is worsened where forfaiting would have left it intact. That point appeared in neither quotation and weighs more than the rate gap. On the risk next, and this is graver: acceptance has not been pronounced and two technical reservations are open. Non-recourse forfaiting would not have transferred that risk in any event, the transferor warranting the existence and validity of the receivable, and the policy does not cover it either since a commercial dispute is an exclusion. The manufacturer therefore did not choose between two protections, it chose between two financings while leaving its real risk bare. The conclusion is not that it should have forfaited: it is that the question to handle first is lifting the reservations and obtaining acceptance, because while they remain open neither technique protects, and the choice between them is then made on the balance sheet rather than on the headline rate.
- 01A receivable sold without recourse leaves the balance sheet; an insured receivable stays on it, conditionally covered, and the risk remains until the insurer pays.
- 02The forfaiter sells a certainty, the insurer sells a conditional cover: the cost gap measures that difference, not greed.
- 03Without recourse does not mean without exception: the transferor warrants the existence and validity of the receivable, hence its own performance.
- 04Forfaiting and insurance combine more often than they compete, and assigning the policy's benefit stacks two logics that must be written down.
- 05Structure designates the technique: a single documented receivable for forfaiting, a regular flow for insurance, and the reverse is expensive.